Sean Stalfort, Director at Dova Pharmaceuticals Inc. (DOVA), bought 31,000 shares at $6.26 ($194K) on 2018-12-20, disclosed to the SEC on 2018-12-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |